We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
-4.53%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$428M
AUM Growth
+$11.3M
Cap. Flow
+$27.5M
Cap. Flow %
6.43%
Top 10 Hldgs %
8.45%
Holding
777
New
181
Increased
140
Reduced
102
Closed
354

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$3.76M
2
ETN icon
Eaton
ETN
+$3.69M
3
LYFT icon
Lyft
LYFT
+$3.26M
4
HLT icon
Hilton Worldwide
HLT
+$3.26M
5
XYL icon
Xylem
XYL
+$3.11M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$3.4M
2
VRSN icon
VeriSign
VRSN
+$2.68M
3
SNPS icon
Synopsys
SNPS
+$2.57M
4
GL icon
Globe Life
GL
+$2.4M
5
MDLZ icon
Mondelez International
MDLZ
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Industrials 17.12%
3 Healthcare 13.81%
4 Consumer Discretionary 12.81%
5 Financials 12.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCI icon
676
Rogers Communications
RCI
$18.8B
– –
-11,600
Closed -$476K
RDY icon
677
Dr. Reddy's Laboratories
RDY
$9.8B
– –
-19,325
Closed -$283K
REGN icon
678
Regeneron Pharmaceuticals
REGN
$72.9B
– –
-300
Closed -$289K
RGLD icon
679
Royal Gold
RGLD
$16.6B
– –
-6,032
Closed -$735K
RIVN icon
680
Rivian
RIVN
$23.6B
– –
-75,800
Closed -$830K
RKT icon
681
Rocket Companies
RKT
$38.8B
– –
-10,313
Closed -$150K
RLAY icon
682
Relay Therapeutics
RLAY
$4B
– –
-21,000
Closed -$174K
ROIV icon
683
Roivant Sciences
ROIV
$23.6B
– –
-42,700
Closed -$450K
ROL icon
684
Rollins
ROL
$18.6B
– –
-6,300
Closed -$292K
RPM icon
685
RPM International
RPM
$13.8B
– –
-4,710
Closed -$560K
RPRX icon
686
Royalty Pharma
RPRX
$26.2B
– –
-7,900
Closed -$240K
RSG icon
687
Republic Services
RSG
$67.4B
– –
-7,900
Closed -$1.51M
RSI icon
688
Rush Street Interactive
RSI
$3.17B
– –
-10,300
Closed -$67.1K
RTX icon
689
RTX Corp
RTX
$290B
– –
-3,300
Closed -$322K
RUN icon
690
Sunrun
RUN
$2.26B
– –
-24,900
Closed -$328K
RUSHA icon
691
Rush Enterprises Class A
RUSHA
$6.34B
– –
-5,839
Closed -$313K
RVMD icon
692
Revolution Medicines
RVMD
$38.5B
– –
-9,200
Closed -$297K
RVTY icon
693
Revvity
RVTY
$12.6B
– –
-4,900
Closed -$515K
RY icon
694
Royal Bank of Canada
RY
$287B
– –
-2,200
Closed -$222K
RYAAY icon
695
Ryanair
RYAAY
$30B
– –
-10,000
Closed -$582K
SAGE
696
DELISTED
Sage Therapeutics
SAGE
– –
-10,570
Closed -$198K
SAIA icon
697
Saia
SAIA
$10.5B
– –
-2,029
Closed -$1.19M
SAM icon
698
Boston Beer
SAM
$1.95B
– –
-674
Closed -$205K
SANM icon
699
Sanmina
SANM
$8.78B
– –
-6,137
Closed -$382K
ECHO
700
EchoStar
ECHO
$24.3B
– –
-20,000
Closed -$285K
26 27
28
29 30

Similar funds

PC
Permanens Capital New York $776M AUM 30.08% 1-Year Est. Return
TCM
Twin Capital Management Mcmurray, Pennsylvania $776M AUM 28.34% 1-Year Est. Return
BPIM
Brant Point Investment Management New York $776M AUM 41.18% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $775M AUM 18.57% 1-Year Est. Return
LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
BIA
Biondo Investment Advisors Milford, Pennsylvania $780M AUM 21.03% 1-Year Est. Return
SC
Sylebra Capital Palo Alto, California $774M AUM 56.69% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $781M AUM 27.1% 1-Year Est. Return

AXQ Capital's Q2 2024 Portfolio in Review

As of Q2 2024, AXQ Capital held 777 positions worth $428M, up 2.7% from $417M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

AXQ Capital deployed $27.5M of net new capital in Q2 2024, opening 181 new positions and adding to 140 existing holdings. Its largest new stake was Walgreens Boots Alliance: 221,738 shares worth $2.68M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $1.57M trimmed.

  • AXQ Capital's largest Q2 2024 buy was Walgreens Boots Alliance: 221,738 shares worth $2.68M.
  • AXQ Capital added most to Xylem in Q2 2024, an estimated $3.11M increase.
  • AXQ Capital's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.57M.
  • AXQ Capital fully exited S&P Global in Q2 2024, selling an estimated $3.4M.
  • AXQ Capital's ten largest holdings make up 8.5% of its $428M portfolio in Q2 2024.
  • AXQ Capital opened 181 new positions and closed 354 in Q2 2024.
  • AXQ Capital's portfolio value rose 2.7% quarter-over-quarter to $428M.

Based on AXQ Capital's 13F filing for Q2 2024, filed 13 Aug 2024.